UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Human mutation, ISSN 1059-7794, 01/2013, Volume 34, Issue 1, pp. 83 - 87
apolipoprotein E | APOE | ADH | LDL | hypercholesterolemia | Hypercholesterolemia | Apolipoprotein E | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Haplotypes | Humans | Middle Aged | Family Health | Male | Apolipoproteins E - metabolism | Young Adult | Chromosomes, Human, Pair 19 - genetics | Gene Deletion | Adult | Female | Child | Protein Structure, Tertiary | Genetic Predisposition to Disease - genetics | Protein Structure, Secondary | Cholesterol, HDL - metabolism | Models, Molecular | Cholesterol - metabolism | Apolipoproteins E - chemistry | Triglycerides - metabolism | Pedigree | Apolipoproteins E - genetics | Adolescent | Cholesterol, LDL - metabolism | Mutation | Hyperlipoproteinemia Type II - genetics | Low density lipoproteins | Genomics | Genetic research | Genetic aspects | Triglycerides | Blood lipids | Apolipoproteins | Cholesterol | Index Medicus | mutation | Apolipoproteine E | low-density lipoproteins (LDL) | linkage analysis | Autosomal Dominant Hypercholesterolemia (ADH)
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 7, pp. 1466 - 1469
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 09/2010, Volume 33, Issue 3, pp. 375 - 386
Lipopolysaccharide Receptors - physiology | Reactive Oxygen Species - metabolism | Humans | GPI-Linked Proteins | Viruses - immunology | Animals | Antigen Presentation | Nucleic Acids - physiology | Receptors, IgG - analysis | Toll-Like Receptor 7 - physiology | Toll-Like Receptor 8 - physiology | Lupus Erythematosus, Systemic - immunology | Myeloid Differentiation Factor 88 - physiology | HLA-DR Antigens - analysis | Mice | Monocytes - physiology | Cytokines - biosynthesis | Studies | Flow cytometry | Cytokines | Acids | Principal components analysis | Genomes | Gene expression | Experiments | Viral infections | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Evidence-based medicine | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Index Medicus | Abridged Index Medicus | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
5.
Full Text
Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis
The Journal of experimental medicine, ISSN 0022-1007, 11/2009, Volume 206, Issue 12, pp. 2583 - 2591
Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Hypersensitivity, Delayed - genetics | Tuberculosis - epidemiology | Quantitative Trait Loci - immunology | Humans | South Africa - epidemiology | Chromosomes, Human, Pair 5 - immunology | Male | Chromosome Mapping | Chromosomes, Human, Pair 11 - genetics | Dopamine Plasma Membrane Transport Proteins - genetics | Hypersensitivity, Delayed - immunology | Tuberculin Test | Dopamine Plasma Membrane Transport Proteins - immunology | Endemic Diseases | Tuberculosis - immunology | Mycobacterium tuberculosis | Tuberculosis - genetics | Female | Tuberculin - pharmacology | Tuberculin - immunology | Chromosomes, Human, Pair 11 - immunology | Chromosomes, Human, Pair 5 - genetics | Quantitative Trait Loci - genetics | Siblings | Index Medicus | Brief Definitive Report
Journal Article
Genes chromosomes & cancer, ISSN 1045-2257, 03/2016, Volume 55, Issue 3, pp. 251 - 267
Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Signal Transduction | Humans | Middle Aged | Interferon Regulatory Factors - metabolism | Male | NF-kappa B - metabolism | Lymphoma, Large B-Cell, Diffuse - metabolism | Exome | Aged, 80 and over | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | DNA, Neoplasm - genetics | Mutation | High-Throughput Nucleotide Sequencing - methods | Lymphoma, Large B-Cell, Diffuse - genetics | Genetic research | Lymphomas | Genetic aspects | Tumor proteins | Analysis | Genomics | Index Medicus | Life Sciences
Journal Article
The lancet oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 549 - 561
Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | Risk Assessment - methods | Lymphoma, Follicular - drug therapy | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Proportional Hazards Models | Male | Gene Expression Profiling | Randomized Controlled Trials as Topic | Rituximab - administration & dosage | Clinical Trials, Phase III as Topic | RNA, Neoplasm - analysis | Lymphoma, Follicular - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Internationality | Progression-Free Survival | Female | Maintenance Chemotherapy | Retrospective Studies | Lymphomas | Genetic aspects | Patient outcomes | Analysis | Genes | Cancer | Index Medicus | Risk factors in diseases | Limfomes | Diagnosis | Gene expression | Expressió gènica | Factors de risc en les malalties | Diagnòstic | Life Sciences
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 07/2017, Volume 65, Issue 2, pp. 282 - 291
Porphyromonas | hidradenitis suppurativa | Prevotella | soft tissue and skin infections | Fusobacterium | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Metagenomics | Hidradenitis Suppurativa - physiopathology | Prospective Studies | Skin - microbiology | Bacteria, Anaerobic - physiology | Humans | Male | Bacteria, Anaerobic - genetics | Gram-Negative Bacteria - isolation & purification | Hidradenitis Suppurativa - microbiology | Bacteria, Anaerobic - isolation & purification | Microbiota | Soft Tissue Infections - microbiology | Quality of Life | Adult | Female | Gram-Negative Bacteria - genetics | High-Throughput Nucleotide Sequencing - methods | Prevotella - isolation & purification | Skin - pathology | Microbiological research | Skin diseases | Care and treatment | Research | Anaerobic infections | Quality of life | Anaerobic microorganisms | rRNA 16S | Commensals | Genomics | Infections | Gene libraries | Antiinfectives and antibacterials | Gene sequencing | Body mass index | Taxa | Microorganisms | Anaerobes | Next-generation sequencing | Remission | Bacteria | Lesions | Construction | Antimicrobial agents | Abundance | Inflammation | Ribonucleic acid--RNA | Paving | Body mass | Actinomycetes | Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 06/2007, Volume 39, Issue 6, pp. 776 - 780
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Mitochondrial Diseases - pathology | Ribonucleotide Reductases - physiology | Mitochondria, Muscle | Humans | Molecular Sequence Data | Male | Lod Score | Tumor Suppressor Protein p53 - genetics | Mitochondrial Diseases - etiology | DNA, Mitochondrial - genetics | DNA Mutational Analysis | Gene Deletion | Cell Cycle Proteins - genetics | Fibroblasts | Female | Infant, Newborn | Cells, Cultured | Tumor Suppressor Protein p53 - metabolism | Mutation - genetics | Mice, Knockout | Homozygote | Animals | Pedigree | Mice | Ribonucleotide Reductases - genetics | Cell Cycle Proteins - physiology | Mitochondrial DNA | Research | Gene mutations | Properties | Ribonucleoside reductase | Genetics | Oxidation | Mutation | Rodents | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 02/2012, Volume 119, Issue 8, pp. 1901 - 1903
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Prognosis | Immunoblastic Lymphadenopathy - genetics | Gene Frequency | Humans | Kaplan-Meier Estimate | Lymphoma, T-Cell, Peripheral - genetics | Genotype | Isocitrate Dehydrogenase - genetics | Male | Mutation Rate | Immunoblastic Lymphadenopathy - enzymology | Lymphoma, T-Cell - genetics | Lymphoma, T-Cell, Peripheral - enzymology | Lymphoma, T-Cell - enzymology | Lymphoma, T-Cell, Peripheral - pathology | Lymphoma, T-Cell - pathology | Female | Immunoblastic Lymphadenopathy - pathology | Aged | Mutation | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia | Brief Report
Journal Article